Life sciences venture firm Foresite Capital said today that it raised a record $668 million for its fourth fund, bringing its assets-under-management tally to $2 billion.
San Francisco-based Foresite was founded in 2011 by former Theravance co-founder & CEO Dr. Jim Tananbaum. Investors in its fourth fund include “a significant representation of existing investors, including university endowments, pension funds, insurance companies and foundations” and some new investors, the company said today.
Get the full story at our sister site, Drug Delivery Business News.
The post Venture fund Foresite Capital raises largest-ever $668m fund appeared first on MassDevice.
from MassDevice https://ift.tt/2rk03Lt
Cap comentari:
Publica un comentari a l'entrada